Williamson made president and CBO of Triumvira
Plus new heads of strategy, CMC at Actinium, and updates from Telegraph Hill and Sebela
T cell therapy company Triumvira Immunologics Inc. hired Robert Williamson as president and CBO to lead business development and strategy. Williamson was CBO and CFO at OncoMyx Therapeutics Inc., and president and CEO at BioTheryX Inc.
Radiotherapy company Actinium Pharmaceuticals Inc. (NYSE-A:ATNM) hired Jenny Hsieh as chief strategy officer, Sunitha Lakshminarayanan as SVP, head of CMC and product development, and Stephen Dressel as VP of strategic finance and analysis. Hsieh was head of corporate strategy at Immunomedics Inc.; Lakshminarayanan was executive director of global process engineering in the cell therapy division of Bristol Myers Squibb Co. (NYSE:BMY); and Dressel was a senior director of financial planning and analysis at Dewpoint Therapeutics Inc...